First reported 21 hours ago -
Updated 18 hours ago -
Kolltan Pharmaceuticals reported the acquisition of Xetrios Therapeutics, a company founded by Greg Lemke, Ph.D., of the Salk Institute for Biological Studies in San Diego, California, Carla Rothlin, Ph.D., of Yale University
, and biotech entrepreneur ...
[Published Street Sweeper - 18 hours ago]